
Researchers have found that a suppressed early immune response and damaged blood vessel coatings drive severe dengue, uncovering crucial gene markers that could predict life-threatening complications.
What to know about New genetic clues could lead to early detection
New study shows how a molecular chain reaction inside human blood explains why a routine mosquito-borne infection can rapidly turn life-threatening. By analysing the genetic activity of dengue patients at the earliest stages of illness, researchers from the CSIR-Institute of Genomics and Integrative Biology, Ashoka University, the Academy of Scientific and Innovative Research (AcSIR), and Max Super Speciality Hospital in New Delhi found that the most severe cases occur because the initial antiviral defences of the body’s immune system are suppressed. This early immune silence allows the virus to flourish unchecked, triggering a dangerous cascade that destroys blood platelets and causes vital blood vessels to leak.
Dengue virus infects an estimated 390 million people worldwide each year, with India alone carrying roughly one-third of the global burden. Transmitted by the Aedes aegypti mosquito, the infection often leads to sudden fever, severe headaches, and muscle pain. For most, the illness resolves within a week. However, a vulnerable fraction of patients suddenly deteriorate, experiencing plummeting platelet counts and plasma leaking out of their circulatory system into surrounding body cavities. Because this collapse can happen without clear warning, identifying which patients will develop severe complications has been one of the challenges facing doctors in tropical emergency rooms.
To find an early marker, the research team examined 112 patients who arrived at the hospital during the acute phase of dengue infection. They extracted total ribonucleic acid (RNA) from each patient’s blood to observe which genes were actively switched on or off. They then applied an analytical technique called weighted gene co-expression network analysis. Much like mapping a complex social network, this method groups thousands of interacting genes into collaborative modules, allowing scientists to see how broad biological networks coordinate their behaviour in response to disease.
Scientists long suspected that severe illness was primarily driven by a massive, hyperactive inflammatory storm. In contrast, the new findings show that patients showing clinical warning signs and dangerous platelet loss exhibited a severely depressed innate immune state. Crucial chemical alarms known as cytokines, including molecules named CXCL8 and interleukin-1 beta, were significantly turned down rather than up. The subdued state causes the body’s early interferon security alarm to fail and not mobilise frontline defences. Without resistance, the dengue virus multiplies rapidly and places enormous stress on the circulatory system.
Key context and latest developments
This viral surge triggers a secondary crisis within the vascular network. As platelets are cleared from the bloodstream in huge numbers, the physical integrity of the blood vessels breaks down. The researchers discovered that this vascular leakage is driven by non-inflammatory damage to the endothelial glycocalyx, a thin, sugary protective gel that coats the inner walls of our blood vessels. In severe patients, genes responsible for sugar modifications, known as O-linked glycosylation, were heavily overactive, while structural maintenance genes such as cortactin, or CTTN, were downregulated. This molecular disruption strips away the protective barrier of blood vessel linings, allowing fluids to escape into surrounding tissues independently of traditional swelling or fever mechanisms.
The study also pinpointed several genes that could serve as early warning clues for hospital wards. A gene called IFI44L, which regulates interferon signalling, showed a dramatic shift in activity between patients with moderately low platelets and those whose counts crashed below critical safety thresholds. Simultaneously, the structural gene CTTN demonstrated the strongest mathematical correlation with falling platelets, serving as a direct window into blood vessel fragility. This research also bridges international observations, corroborating findings from clinical studies in Brazil regarding interferon genes while pinpointing unique blood-vessel maintenance signatures relevant to populations in South Asia.
The researchers, however, acknowledged that the investigation was cross-sectional, capturing a snapshot of patient blood at a single moment during early infection. As a result, the study could not track the dynamic rise and fall of these genetic signals through patient recovery, highlighting the need for future longitudinal studies.
By identifying the exact genes that signal early disease escalation, clinicians could detect severe dengue days before clinical warning signs appear. Understanding that plasma leakage is linked to the destruction of the blood vessel’s sugar coating could also open up entirely new avenues for drug development. In countries where hospital wards are regularly overwhelmed by seasonal epidemics, these molecular insights could save critical healthcare resources and ultimately prevent escalations.
